Approval · Notice of Compliance 14712 · 2013
NTP-INDAPAMIDE: Notice of Compliance 14712
Issued September 9, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14712
- Date
- September 9, 2013
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger/buyout
- Therapeutic class
- Diuretic, antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NTP-INDAPAMIDE | 02362015 | Cancelled Pre Market |
Medicinal ingredients
- INDAPAMIDE 2.5 MG per TAB